Differences and Similarities between the Lung Transcriptomic Profiles of COVID-19, COPD, and IPF Patients: A Meta-Analysis Study of Pathophysiological Signaling Pathways
Abstract
:1. Introduction
2. Methods
2.1. Expression Datasets
2.1.1. COVID-19 Dataset
2.1.2. IPF Dataset
2.1.3. COPD Dataset
2.2. Interactome Analysis
2.2.1. Data Sources
2.2.2. COVID-19, IPF, and COPD Interactomes
2.3. Functional Characterization
2.4. Functional Connectivity
3. Results
3.1. Data Analysis
3.2. Interactome Analysis
3.3. Functional Characterization
3.4. Network Comparisons
3.4.1. COVID-19–IPF Connectivity
3.4.2. COVID-19–COPD Connectivity
3.4.3. IPF–COPD Connectivity
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
References
- Olliaro, P.L. An integrated understanding of long-term sequelae after acute COVID-19. Lancet Respir. Med. 2021, 9, 679–680. [Google Scholar] [CrossRef]
- Mo, X.; Jian, W.; Su, Z.; Chen, M.; Peng, H.; Peng, P.; Lei, C.; Chen, R.; Zhong, N.; Li, S. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur. Respir. J. 2020, 55, 2001217. [Google Scholar] [CrossRef] [PubMed]
- Sibila, O.; Albacar, N.; Perea, L.; Faner, R.; Torralba, Y.; Hernandez-Gonzalez, F.; Moisés, J.; Sanchez-Ruano, N.; Sequeira-Aymar, E.; Badia, J.R.; et al. Lung Function sequelae in COVID-19 Patients 3 Months After Hospital Discharge. Arch. Bronconeumol. 2021, 57, 59–61. [Google Scholar] [CrossRef] [PubMed]
- Wang, Y.; Dong, C.; Hu, Y.; Li, C.; Ren, Q.; Zhang, X.; Shi, H.; Zhou, M. Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study. Radiology 2020, 296, E55–E64. [Google Scholar] [CrossRef] [Green Version]
- Spagnolo, P.; Balestro, E.; Aliberti, S.; Cocconcelli, E.; Biondini, D.; Della Casa, G.; Sverzellati, N.; Maher, T.M. Pulmonary fibrosis secondary to COVID-19: A call to arms? Lancet Respir. Med. 2020, 8, 750–752. [Google Scholar] [CrossRef]
- Zhang, P.; Li, J.; Liu, H.; Han, N.; Ju, J.; Kou, Y.; Chen, L.; Jiang, M.; Pan, F.; Zheng, Y.; et al. Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: A 15-year follow-up from a prospective cohort study. Bone Res. 2020, 8, 8, Erratum in Bone Res. 2020, 8, 34. [Google Scholar] [CrossRef] [Green Version]
- Wu, X.; Dong, D.; Ma, D. Thin-Section Computed Tomography Manifestations During Convalescence and Long-Term Follow-Up of Patients with Severe Acute Respiratory Syndrome (SARS). Med. Sci. Monit. 2016, 22, 2793–2799. [Google Scholar] [CrossRef] [Green Version]
- Wu, X.; Liu, X.; Zhou, Y.; Yu, H.; Li, R.; Zhan, Q.; Ni, F.; Fang, S.; Lu, Y.; Ding, X.; et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: A prospective study. Lancet Respir. Med. 2021, 9, 747–754. [Google Scholar] [CrossRef]
- Vijayakumar, B.; Tonkin, J.; Devaraj, A.; Philip, K.E.J.; Orton, C.M.; Desai, S.R.; Shah, P.L. CT Lung Abnormalities after COVID-19 at 3 Months and 1 Year after Hospital Discharge. Radiology 2022, 303, 444–454. [Google Scholar] [CrossRef]
- Besutti, G.; Monelli, F.; Schirò, S.; Milone, F.; Ottone, M.; Spaggiari, L.; Facciolongo, N.; Salvarani, C.; Croci, S.; Pattacini, P.; et al. Follow-Up CT Patterns of Residual Lung Abnormalities in Severe COVID-19 Pneumonia Survivors: A Multicenter Retrospective Study. Tomography 2022, 8, 1184–1195. [Google Scholar] [CrossRef]
- Ambardar, S.; Hightower, S.; Huprikar, N.; Chung, K.; Singhal, A.; Collen, J. Post-COVID-19 Pulmonary Fibrosis: Novel Sequelae of the Current Pandemic. J. Clin. Med. 2021, 10, 2452. [Google Scholar] [CrossRef] [PubMed]
- Chilosi, M.; Poletti, V.; Rossi, A. The pathogenesis of COPD and IPF: Distinct horns of the same devil? Respir. Res. 2012, 13, 3. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lee, H.; Choi, H.; Yang, B.; Lee, S.-K.; Park, T.S.; Park, D.W.; Moon, J.-Y.; Kim, T.-H.; Sohn, J.W.; Yoon, H.J.; et al. Interstitial lung disease increases susceptibility to and severity of COVID-19. Eur. Respir. J. 2021, 58, 2004125. [Google Scholar] [CrossRef] [PubMed]
- Polverino, F.; Kheradmand, F. COVID-19, COPD, and AECOPD: Immunological, Epidemiological, and Clinical Aspects. Front. Med. 2021, 7, 627278. [Google Scholar] [CrossRef]
- Desai, N.; Neyaz, A.; Szabolcs, A.; Shih, A.R.; Chen, J.H.; Thapar, V.; Nieman, L.T.; Solovyov, A.; Mehta, A.; Lieb, D.J.; et al. Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection. Nat. Commun. 2020, 11, 6319. [Google Scholar] [CrossRef]
- DePianto, D.J.; Chandriani, S.; Abbas, A.R.; Jia, G.; N’Diaye, E.N.; Caplazi, P.; E Kauder, S.; Biswas, S.; Karnik, S.K.; Ha, C.; et al. Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis. Thorax 2014, 70, 48–56. [Google Scholar] [CrossRef] [Green Version]
- Van Dyck, E.; Nazarov, P.V.; Muller, A.; Nicot, N.; Bosseler, M.; Pierson, S.; Van Moer, K.; Palissot, V.; Mascaux, C.; Knolle, U.; et al. Bronchial airway gene expression in smokers with lung or head and neck cancer. Cancer Med. 2014, 3, 322–336. [Google Scholar] [CrossRef] [Green Version]
- Barabási, A.-L.; Gulbahce, N.; Loscalzo, J. Network medicine: A network-based approach to human disease. Nat. Rev. Genet. 2010, 12, 56–68. [Google Scholar] [CrossRef] [Green Version]
- Jassal, B.; Matthews, L.; Viteri, G.; Gong, C.; Lorente, P.; Fabregat, A.; Sidiropoulos, K.; Cook, J.; Gillespie, M.; Haw, R.; et al. The reactome pathway knowledgebase. Nucleic Acids Res. 2020, 48, D498–D503. [Google Scholar] [CrossRef]
- Von Mering, C. STRING: A database of predicted functional associations between proteins. Nucleic Acids Res. 2003, 31, 258–261. [Google Scholar] [CrossRef]
- Huttlin, E.L.; Bruckner, R.J.; Paulo, J.A.; Cannon, J.R.; Ting, L.; Baltier, K.; Colby, G.; Gebreab, F.; Gygi, M.P.; Parzen, H.; et al. Architecture of the human interactome defines protein communities and disease networks. Nature 2017, 545, 505–509. [Google Scholar] [CrossRef] [PubMed]
- Wang, Z.; Zhang, J. In Search of the Biological Significance of Modular Structures in Protein Networks. PLoS Comput. Biol. 2007, 3, e107. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Enright, A.J.; Van Dongen, S.; Ouzounis, C.A. An efficient algorithm for large-scale detection of protein families. Nucleic Acids Res. 2002, 30, 1575–1584. [Google Scholar] [CrossRef]
- The Gene Ontology Consortium. The Gene Ontology Resource: 20 years and still GOing strong. Nucleic Acids Res. 2019, 47, D330–D338. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ogris, C.; Guala, D.; Helleday, T.; Sonnhammer, E. A novel method for crosstalk analysis of biological networks: Improving accuracy of pathway annotation. Nucleic Acids Res. 2016, 45, e8. [Google Scholar] [CrossRef] [Green Version]
- McCormack, T.; Frings, O.; Alexeyenko, A.; Sonnhammer, E.L.L. Statistical Assessment of Crosstalk Enrichment between Gene Groups in Biological Networks. PLoS ONE 2013, 8, e54945. [Google Scholar] [CrossRef] [Green Version]
- Ogris, C.; Helleday, T.; Sonnhammer, E.L. PathwAX: A web server for network crosstalk based pathway annotation. Nucleic Acids Res. 2016, 44, W105–W109. [Google Scholar] [CrossRef] [Green Version]
- Ghiassian, S.D.; Menche, J.; Barabási, A.-L. A DIseAse MOdule Detection (DIAMOnD) Algorithm Derived from a Systematic Analysis of Connectivity Patterns of Disease Proteins in the Human Interactome. PLoS Comput. Biol. 2015, 11, e1004120. [Google Scholar] [CrossRef]
- Hennig, C. fpc: Flexible Procedures for Clustering. R Package Version 2.1-10. R Package Version. 2015, Volume 2. Available online: http://cran.r-project.org/package=fpc (accessed on 28 April 2022).
- Galili, T. dendextend: An R package for visualizing, adjusting and comparing trees of hierarchical clustering. Bioinformatics 2015, 31, 3718–3720. [Google Scholar] [CrossRef] [Green Version]
- Yu, M.; Liu, Y.; Xu, D.; Zhang, R.; Lan, L.; Xu, H. Prediction of the Development of Pulmonary Fibrosis Using Serial Thin-Section CT and Clinical Features in Patients Discharged after Treatment for COVID-19 Pneumonia. Korean J. Radiol. 2020, 21, 746–755. [Google Scholar] [CrossRef]
- Zhao, Y.-M.; Shang, Y.-M.; Song, W.-B.; Li, Q.-Q.; Xie, H.; Xu, Q.-F.; Jia, J.-L.; Li, L.-M.; Mao, H.-L.; Zhou, X.-M.; et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. eClinicalMedicine 2020, 25, 100463. [Google Scholar] [CrossRef] [PubMed]
- Desai, O.; Winkler, J.; Minasyan, M.; Herzog, E.L. The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis. Front. Med. 2018, 5, 43. [Google Scholar] [CrossRef] [PubMed]
- She, Y.X.; Yu, Q.Y.; Tang, X.X. Role of interleukins in the pathogenesis of pulmonary fibrosis. Cell Death Discov. 2021, 7, 52. [Google Scholar] [CrossRef] [PubMed]
- Shi, J.; Li, F.; Luo, M.; Wei, J.; Liu, X. Distinct Roles of Wnt/β-Catenin Signaling in the Pathogenesis of Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis. Mediat. Inflamm. 2017, 2017, 3520581. [Google Scholar] [CrossRef] [Green Version]
- A Baarsma, H.; Königshoff, M. ‘WNT-er is coming’: WNT signalling in chronic lung diseases. Thorax 2017, 72, 746–759. [Google Scholar] [CrossRef] [Green Version]
- Burgy, O.; Königshoff, M. The WNT signaling pathways in wound healing and fibrosis. Matrix Biol. 2018, 68, 67–80. [Google Scholar] [CrossRef]
- Nielsen, C.H.; Fischer, E.M.; Leslie, R.G.Q. The role of complement in the acquired immune response. Immunology 2000, 100, 4–12. [Google Scholar] [CrossRef]
- Hsu, Y.-P.; Staton, C.A.; Cross, N.; Buttle, D.J. Anti-angiogenic properties of ADAMTS-4 in vitro. Int. J. Exp. Pathol. 2012, 93, 70–77. [Google Scholar] [CrossRef]
- Lambert, J.; Makin, K.; Akbareian, S.; Johnson, R.; Alghamdi, A.A.A.; Robinson, S.D.; Edwards, D.R. ADAMTS-1 and syndecan-4 intersect in the regulation of cell migration and angiogenesis. J. Cell Sci. 2020, 133, jcs235762. [Google Scholar] [CrossRef] [Green Version]
- Hirohata, S.; Inagaki, J.; Ohtsuki, T. Diverse Functions of a Disintegrin and Metalloproteinase with Thrombospondin Motif-1. YAKUGAKU ZASSHI 2017, 137, 811–814. [Google Scholar] [CrossRef] [Green Version]
- Katneni, U.K.; Alexaki, A.; Hunt, R.C.; Schiller, T.; DiCuccio, M.; Buehler, P.W.; Ibla, J.C.; Kimchi-Sarfaty, C. Coagulopathy and Thrombosis as a Result of Severe COVID-19 Infection: A Microvascular Focus. Thromb. Haemost. 2020, 120, 1668–1679. [Google Scholar] [CrossRef] [PubMed]
- Rodríguez, C.; Martínez-González, J. The Role of Lysyl Oxidase Enzymes in Cardiac Function and Remodeling. Cells 2019, 8, 1483. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Henrot, P.; Prevel, R.; Berger, P.; Dupin, I. Chemokines in COPD: From Implication to Therapeutic Use. Int. J. Mol. Sci. 2019, 20, 2785. [Google Scholar] [CrossRef] [Green Version]
- Saetta, M.; Mariani, M.; Panina-Bordignon, P.; Turato, G.; Buonsanti, C.; Baraldo, S.; Bellettato, C.M.; Papi, A.; Corbetta, L.; Zuin, R.; et al. Increased Expression of the Chemokine Receptor CXCR3 and Its Ligand CXCL10 in Peripheral Airways of Smokers with Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 2002, 165, 1404–1409. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cosio, M.G.; Majo, J.; Cosio, M.G. Inflammation of the Airways and Lung Parenchyma in COPD. Chest 2002, 121, 160S–165S. [Google Scholar] [CrossRef]
- McMurtry, M.S.; Archer, S.L.; Altieri, D.C.; Bonnet, S.; Haromy, A.; Harry, G.; Bonnet, S.; Puttagunta, L.; Michelakis, E.D. Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension. J. Clin. Investig. 2005, 115, 1479–1491. [Google Scholar] [CrossRef]
- Weiss, A.; Neubauer, M.C.; Yerabolu, D.; Kojonazarov, B.; Schlueter, B.C.; Neubert, L.; Jonigk, D.; Baal, N.; Ruppert, C.; Dorfmuller, P.; et al. Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension. Nat. Commun. 2019, 10, 2204. [Google Scholar] [CrossRef]
- Brown, R.; Nath, S.; Lora, A.; Samaha, G.; Elgamal, Z.; Kaiser, R.; Taggart, C.; Weldon, S.; Geraghty, P. Cathepsin S: Investigating an old player in lung disease pathogenesis, comorbidities, and potential therapeutics. Respir. Res. 2020, 21, 111. [Google Scholar] [CrossRef]
- A Attaway, A.; Zein, J.; Hatipoğlu, U.S. SARS-CoV-2 infection in the COPD population is associated with increased healthcare utilization: An analysis of Cleveland clinic’s COVID-19 registry. eClinicalMedicine 2020, 26, 100515. [Google Scholar] [CrossRef]
- Leung, J.M.; Niikura, M.; Yang, C.W.T.; Sin, D.D. COVID-19 and COPD. Eur. Respir. J. 2020, 56, 2002108. [Google Scholar] [CrossRef]
- Alqahtani, J.S.; Oyelade, T.; Aldhahir, A.M.; Alghamdi, S.M.; Almehmadi, M.; Alqahtani, A.S.; Quaderi, S.; Mandal, S.; Hurst, J.R. Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis. PLoS ONE 2020, 15, e0233147. [Google Scholar] [CrossRef] [PubMed]
- Huguet, E.T.; Gajarte, A.U.; Iturriaga, L.A.R.; Fernandez, L.S.; Malanda, N.M.; Pascual, M.I.; Jorge, R.Z. Alteración funcional pulmonar en el seguimiento precoz de pacientes con neumonía por COVID-19. Arch. Bronconeumol. 2020, 57, 75–76. [Google Scholar] [CrossRef]
biological process | GO:0002376 | immune system process |
biological process | GO:0045087 | innate immune response |
biological process | GO:0006954 | inflammatory response |
biological process | GO:0019882 | antigen processing and presentation |
biological process | GO:0009611 | response to wounding |
biological process | GO:0048771 | tissue remodeling |
biological process | GO:0001837 | epithelial to mesenchymal transition |
biological process | GO:0043043 | peptide biosynthetic process |
biological process | GO:0006766 | vitamin metabolic process |
biological process | GO:0006935 | chemotaxis |
biological process | GO:0001775 | cell activation |
biological process | GO:0008283 | cell population proliferation |
biological process | GO:0050900 | leukocyte migration |
biological process | GO:0048870 | cell motility |
biological process | GO:0051301 | cell division |
biological process | GO:0000278 | mitotic cell cycle |
biological process | GO:0016049 | cell growth |
biological process | GO:0007155 | cell adhesion |
biological process | GO:0007165 | signal transduction |
biological process | GO:0007259 | receptor signaling pathway via JAK-STAT |
biological process | GO:0000165 | MAPK cascade |
biological process | GO:0014065 | phosphatidylinositol 3-kinase signaling |
molecular function | GO:0003824 | catalytic activity |
molecular function | GO:0008009 | chemokine activity |
molecular function | GO:0005125 | cytokine activity |
molecular function | GO:0005216 | ion channel activity |
molecular function | GO:0019814 | immunoglobulin complex |
molecular function | GO:0031012 | extracellular matrix |
molecular function | GO:0008083 | growth factor activity |
molecular function | GO:0003924 | GTPase activity |
molecular function | GO:0016209 | antioxidant activity |
molecular function | GO:0006508 | proteolysis |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Aguilar, D.; Bosacoma, A.; Blanco, I.; Tura-Ceide, O.; Serrano-Mollar, A.; Barberà, J.A.; Peinado, V.I. Differences and Similarities between the Lung Transcriptomic Profiles of COVID-19, COPD, and IPF Patients: A Meta-Analysis Study of Pathophysiological Signaling Pathways. Life 2022, 12, 887. https://doi.org/10.3390/life12060887
Aguilar D, Bosacoma A, Blanco I, Tura-Ceide O, Serrano-Mollar A, Barberà JA, Peinado VI. Differences and Similarities between the Lung Transcriptomic Profiles of COVID-19, COPD, and IPF Patients: A Meta-Analysis Study of Pathophysiological Signaling Pathways. Life. 2022; 12(6):887. https://doi.org/10.3390/life12060887
Chicago/Turabian StyleAguilar, Daniel, Adelaida Bosacoma, Isabel Blanco, Olga Tura-Ceide, Anna Serrano-Mollar, Joan Albert Barberà, and Victor Ivo Peinado. 2022. "Differences and Similarities between the Lung Transcriptomic Profiles of COVID-19, COPD, and IPF Patients: A Meta-Analysis Study of Pathophysiological Signaling Pathways" Life 12, no. 6: 887. https://doi.org/10.3390/life12060887